Celiac Disease Plasma
Powered by BiozAbout:Celiac Disease Plasma is sourced from consented donors with documented celiac disease. These samples support immunoassay and proteomics research, with donor information on condition, demographics, medications and comorbidities.
About Celiac Disease Plasma
Celiac Disease Plasma is sourced from consented donors with documented celiac disease. These samples support immunoassay and proteomics research, with donor information on condition, demographics, medications and comorbidities.
Applications
- Celiac Disease research
- Immunoassay development
- Proteomic research
- Metabolomic research
- Soluble-protein studies
Product Features
- Human plasma
- Donor condition: Celiac Disease
- Consented donor collection
- Research Use Only (RUO)
De-identified Donor Data
- Donor condition/diagnosis and documented clinical phenotype
- Age, gender and race/ethnicity
- Medications and comorbidities
- HLA typing and CMV status
- HIV, HBV, HCV and syphilis testing
- ABO/Rh blood type and country of collection
- Tobacco, alcohol, caffeine and recreational drug use
Donor Stratification
Cohort characteristics include diagnosis and documented clinical phenotype, medication history, comorbidities and demographics.
Donor and clinical data in these lots
Fields recorded on the 8 in-stock lots for this product. Coverage varies by donor; blank fields are not available for that lot.
Donor
- Sex
- 8 of 8 lots
- Age
- 8 of 8 lots
- Race
- 8 of 8 lots
- BMI
- 8 of 8 lots
Clinical history
- Primary diagnosis
- 8 of 8 lots
- Current medications
- 5 of 8 lots
- Comorbidities
- 2 of 8 lots
- Allergies
- 8 of 8 lots
- Infectious disease history
- 8 of 8 lots
Lab results & genotype
- CMV serostatus
- 8 of 8 lots
- ABO / Rh blood type
- 8 of 8 lots
- HLA class I typing
- 8 of 8 lots
- HLA class II typing
- 6 of 8 lots
Lifestyle
- Tobacco use
- 8 of 8 lots
- Alcohol use
- 8 of 8 lots
- Recreational drug use
- 8 of 8 lots
- Caffeine use
- 8 of 8 lots
Collection
- Collection date
- 8 of 8 lots
- Country of collection
- 8 of 8 lots
Need a field that isn't listed, such as disease stage or time since diagnosis?
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Where can I find your complete catalog?
You can find our full product catalog here.
How long can samples be stored?
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
What customization options are available?
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
Do you offer prospective collections?
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
What is the turnaround time for custom collections?
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
Do you have samples in stock?
YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
What does unique donor mean?
Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
Are samples collected under IRB-approved protocols?
YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Frequently Asked Questions
Ask a Question
Pair with a Healthy Control
Match your Celiac Disease Plasma with normal donor samples for comparison
Healthy Plasma
206 In Stock View InventoryNeed a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.